AstraZeneca to buy Alexion in $39bn immunology deal
By Sarah Neville, Donato Paolo Mancini & Arash Massoudi
Big Pharma Deals: AstraZeneca Buying Alexion Pharmaceuticals for $39 Billion
By John Lauerman, Tim Loh & Stephanie Baker
AstraZeneca to Buy Alexion for $39 Billion to Add Rare-Disease Treatments
By Michael de la Merced